Exascale Labs Holdings (NASDAQ:XLAB) reported quarterly losses of $(8.11 thousand) per share. This is a 58.78 percent decrease over losses of $(5.11 thousand) per share from the same period last year. The company reported $14.823 million in sales this quarter. This is a 111.27 percent increase over sales of $7.016 million the same period last year.